Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Capital Expenditures (2017 - 2025)

GeoVax Labs (GOVX) has disclosed Capital Expenditures for 13 consecutive years, with $10718.0 as the latest value for Q2 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to $10718.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $27612.0, a 30.28% decrease, with the full-year FY2024 number at $20653.0, down 57.8% from a year prior.
  • Capital Expenditures was $10718.0 for Q2 2025 at GeoVax Labs, down from $16894.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $62186.0 in Q1 2022 to a low of $6192.0 in Q3 2023.
  • A 5-year average of $25380.6 and a median of $20197.0 in 2022 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: soared 1025.06% in 2021, then plummeted 88.06% in 2023.
  • GeoVax Labs' Capital Expenditures stood at $27789.0 in 2021, then skyrocketed by 86.67% to $51875.0 in 2022, then plummeted by 63.47% to $18949.0 in 2023, then rose by 8.99% to $20653.0 in 2024, then tumbled by 48.1% to $10718.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Capital Expenditures are $10718.0 (Q2 2025), $16894.0 (Q1 2025), and $20653.0 (Q3 2024).